NCT02030340

Brief Summary

Various systems to measure intravesical and intrarectal pressure during urodynamic testing; especially cystometry, exist. Water filled tube -systems are the most commonly used and should be regarded as the contemporary standard. A water filled system is however sensitive to tube and or patient movement artefacts and prone to erroneous calibration. Air charged catheters are less sensitive to patient and especially tubing- movements, and calibrate easier. However, in vitro tests have demonstrated that air charged catheters respond somewhat slower and relatively damped, especially to rapid pressure changes as in (simulated) coughing, in comparison with water filled systems. The clinical relevance of these observations is unknown. This is a study to compare the technical reliability and clinical applicability of the two types of catheter systems for cystometry in a synchronous double catheter testing procedure in a prospective group or patients scheduled for urodynamic investigation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2013

Completed
9 months until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 8, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

January 8, 2014

Status Verified

January 1, 2014

Enrollment Period

8 months

First QC Date

March 6, 2013

Last Update Submit

January 6, 2014

Conditions

Keywords

urodynamic investigationlower urinary tract dysfunctioncatheterair-chargedwater filled

Outcome Measures

Primary Outcomes (1)

  • The difference between the water filled catheter recorded and simultaneously air charged catheter recorded maximum pressure (amplitude)during the bladder filling phase of urodynamic test.

    Null hypothesis: the (absolute mean) difference between the water filled catheter recorded and simultaneously air charged catheter recorded maximum pressure (amplitude) observed with a dominant detrusor pressure event during urodynamic filling as obtained with both systems is close to zero.

    acute comparison during one test with two types of catheter

Secondary Outcomes (1)

  • responses to relevant pressure events: end fill pressure, maximum contraction pressure, maximum pressure at overactive detrusor contraction and maximum cough pressure.

    acute comparison during one test with two types of catheter

Study Arms (1)

Testing Lower urinary tract dysfunction

All patients with lower urinary tract dysfunction where urodynamic diagnosis is required according to standards and (international) practice guidelines will have a synchronous double system (combination of air-charged and water filled) urodynamic test.

Procedure: lower urinary tract dysfunction

Interventions

Urodynamic investigation with a double (two systems: air-charged and water filled) catheter system

Also known as: T-doc air charged catheters.
Testing Lower urinary tract dysfunction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled (on the basis of contemporary clinical standards and protocols) for standard urodynamic investigation.

You may qualify if:

  • (All necessary:)
  • Female gt18 years
  • Scheduled for urodynamic investigation on the basis of contemporary standards and guidelines, because of signs and symptoms of lower urinary tract dysfunction.
  • May perform (not excluded) intermittent (self) catheterisation.
  • No signs of voiding dysfunction (routine outpatient max flow above 20 millilitre per second without postvoid residual)
  • No signs of bladder /pelvic pain syndrome
  • OR:
  • (All necessary)
  • Male or female gt18years
  • Complete spinal cord injury, level above T12, or meningomyelocele unable to void and significantly reduced or no pelvic floor, urethral or bladder sensation.
  • May have (not excluded) 'sacral sparing'; some residual anal sensation
  • Scheduled for urodynamic investigation on the basis of contemporary standards and guidelines, because of signs and symptoms of lower urinary tract dysfunction or because of routine (protocol, guidelines) follow -up.
  • Usually: performing intermittent (self) catheterisation); not excluded.
  • May have (not excluded) indwelling catheter.

You may not qualify if:

  • Unwilling or unfit to sign informed consent.
  • American Society of Anesthesiologists -score gt2; karnovsky lt80percent.
  • Male with normal lower urinary tract sensation.
  • Women with signs of voiding dysfunction.
  • Patients included in scientific studies (for other reasons).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Utrecht

Utrecht, 3584CX, Netherlands

RECRUITING

Related Publications (1)

  • Rosier PF, Gajewski JB, Sand PK, Szabo L, Capewell A, Hosker GL; International Consultation on Incontinence 2008 Committee on Dynamic Testing. Executive summary: The International Consultation on Incontinence 2008--Committee on: "Dynamic Testing"; for urinary incontinence and for fecal incontinence. Part 1: Innovations in urodynamic techniques and urodynamic testing for signs and symptoms of urinary incontinence in female patients. Neurourol Urodyn. 2010;29(1):140-5. doi: 10.1002/nau.20764.

    PMID: 19693949BACKGROUND

Study Officials

  • Peter FW Rosier, MD PhD

    University Medical Center Utrecht, the Netherlands

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peter FW Rosier, MD PhD

CONTACT

Ruud JL Bosch, Prof.

CONTACT

Study Design

Study Type
observational
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer MD PhD

Study Record Dates

First Submitted

March 6, 2013

First Posted

January 8, 2014

Study Start

December 1, 2013

Primary Completion

August 1, 2014

Study Completion

December 1, 2014

Last Updated

January 8, 2014

Record last verified: 2014-01

Locations